11th Circ. Affirms Teva's Win In Suit Over Generic Reglan
A day after the U.S. Supreme Court ruled that generic-drug makers cannot be sued under state law for design defects, the Eleventh Circuit on Tuesday dismissed a consumer's suit claiming Teva...To view the full article, register now.
Already a subscriber? Click here to view full article